Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.
about
The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulationsPharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteersCombination therapy as a tool to prevent emergence of bacterial resistance.Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model.Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.What in vitro models of infection can and cannot do.Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infectionsBactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patientsContinuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Relationships between antimicrobial effect and area under the concentration-time curve as a basis for comparison of modes of antibiotic administration: meropenem bolus injections versus continuous infusionsDevelopment and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost.Comparison of continuous infusion with intermittent bolus administration of cefotaxime on blood and cavity fluid drug concentrations in neonatal foals.Amikacin Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis in Pediatric Cancer Patients.
P2860
Q28485988-88E22373-027B-4EC1-9C48-F8179FAA2A84Q33555775-B18A326C-A6B5-4D33-8AD3-6A6D1B957A38Q33676387-31DE3C12-F8C1-4E53-BBF3-390C07B6F969Q33961767-264F7C5D-5613-4A87-9F5F-2C349F647504Q33975896-40D4E35D-23BE-46B1-A9B8-4FB74C8D8891Q33979347-8C3AC751-A77D-4304-94CA-A6B2A1D930FDQ34252432-D5F509DC-8896-4DEB-884D-F21FBDD48CD3Q34443398-6C247B60-61C7-4939-B71C-6C5C6866DC73Q34922363-28E69A3C-1133-4967-8026-11E37E63AC18Q35123123-839EE0E1-3BD0-4663-8366-5BD4CD094D79Q35124263-02611896-48F1-48D4-AF05-F68E7F5D5C68Q35138316-7FDCA72B-3E92-4E2D-8336-BEDC74A7933BQ37543906-975689C9-9B2A-4F72-B30A-F13A17DB7990Q38004063-D848EA13-05BF-4B80-AF94-FE1F185AE306Q39783646-C1D5C83A-9376-49EF-8D65-DAA5A7D1AF12Q43215544-0B5F59A6-E3FE-4D4E-AC3C-0480CA831CBEQ43808736-A0706EE6-7DD5-4789-BF8A-70F77D7722DEQ44557053-EA396C3C-10FB-45B7-8C1F-9C9E1C07E4AAQ48528055-FA677EC5-17FB-4467-9A5B-90BA5B08C113
P2860
Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Pharmacodynamics of ceftazidim ...... n an in vitro infection model.
@ast
Pharmacodynamics of ceftazidim ...... n an in vitro infection model.
@en
type
label
Pharmacodynamics of ceftazidim ...... n an in vitro infection model.
@ast
Pharmacodynamics of ceftazidim ...... n an in vitro infection model.
@en
prefLabel
Pharmacodynamics of ceftazidim ...... n an in vitro infection model.
@ast
Pharmacodynamics of ceftazidim ...... n an in vitro infection model.
@en
P2093
P2860
P356
P1476
Pharmacodynamics of ceftazidim ...... n an in vitro infection model.
@en
P2093
P2860
P304
P356
10.1128/AAC.39.8.1797
P407
P577
1995-08-01T00:00:00Z